India to Australia: Acyclovir Export Trade Route
India has recorded 22 verified shipments of Acyclovir exported to Australia, representing a combined trade value of $592.1K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $26.9K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 52% of total export value with 18 shipments worth $307.4K USD. On the buying side, XXNDOXXPTYXXTD is the largest importer in Australia with $284.5K USD in purchases. The top 3 suppliers — CIPLA LIMITED, HETERO LABS LIMITED, YASHICA PHARMACEUTICALS PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Acyclovir corridor is one of India's established pharmaceutical export routes, with 22 shipments documented worth a combined $592.1K USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's acyclovir manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $26.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with acyclovir's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 9.4%, placing it at rank #12 among India's top acyclovir export destinations globally.
On the import side, key buyers of Indian acyclovir in Australia include XXNDOXXPTYXXTD, KEY PHARMACEUTICALS PTY LTD, NOUMED PHARMACEUTICALS PTY LTD and 4 others. XXNDOXXPTYXXTD is the single largest importer with 1 shipments valued at $284.5K USD.
